September 10, 2007 — Elsevier, a publisher of scientific, technical and medical information products and services, announced the launch of OncologySTAT a free website featuring high-quality, scientifically-based oncology and cancer care information and education.

The site is aimed at more than 1 million US oncologists, hematologists, oncology nurses, and all other healthcare professionals involved in the treatment, care and diagnosis of patients with cancer.

OncologySTAT offers multiple professional cancer information resources in a single online location. Healthcare professionals who register with the site can search and download current peer-reviewed articles from more than 100 Elsevier cancer related journals. Clinicians can stay up to date and build expertise leading to improved patient care and enhanced practice management through features such as journal and MEDLINE search, professional drug and interaction databases, news, blogs and webinars. OncologySTAT also provides cancer patients, survivors and caregivers with access to the same information used by experienced cancer care professionals.

Oncology is the second largest and fastest growing therapy class in the world. Cancer professionals are challenged by the multitude of information sources available, and by the frequency in which new information is published.

The site operates independently from any particular professional society or sponsor. However, the site offers multiple marketing and promotional opportunities, including targeted advertising and sponsorship of specific site sections or content types.

For more information: www.oncologystat.com and www.elsevier.com


Related Content

News | Artificial Intelligence

September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a ...

Time September 07, 2023
arrow
News | Radiology Business

July 27, 2023 — Privately-held biotech company TAE Life Sciences has announced that its board of directors has appointed ...

Time July 27, 2023
arrow
News | Interventional Radiology

Varian announced it has signed an asset purchase agreement to acquire the Boston Scientific portfolio of drug-loadable microsphere and bland embolic bead products for treating arteriovenous malformations and hypervascular tumors. When completed, this acquisition, in combination with the recent acquisitions of Endocare and Alicon, will expand Varian's portfolio of multidisciplinary integrated cancer care solutions.

Time July 03, 2019
arrow
Technology | Focused Ultrasound Therapy

Insightec announced that the U.S. Food and Drug Administration (FDA) has approved an expansion of the indication of Exablate Neuro to include the treatment of patients with tremor-dominant Parkinson's disease (PD).

Time December 21, 2018
arrow
Videos | Radiation Oncology

Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation ...

Time November 06, 2018
arrow
News | Radiation Dose Management

AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

Time September 24, 2018
arrow
News | Radiation Oncology

World Cancer Day takes place annually on Feb. 4 to raise awareness and education in the media, governments and people ...

Time February 01, 2018
arrow
News | Oncology Related Products

December 19, 2016 — Children’s National Health System and Celsion Corp. announced in November the launch of a clinical ...

Time December 19, 2016
arrow
News | Clinical Decision Support

October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use ...

Time October 27, 2016
arrow
News | Ultrasound Imaging

September 12, 2016 — Tiny microbubbles are being used to more effectively identify liver tumors, according to a study ...

Time September 12, 2016
arrow
Subscribe Now